University of Pecs   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Pozsony Hungary (1912)

Organization Overview

First Clinical Trial
2008
NCT00638326
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Department of Anesth.and Int Care,University of Pecs, Medical School | Department of Anesthesiology and Intensive Therapy, University of Pecs, Hungary | Department of Otorhinolaryngology, University of Pecs, Hungary | Department of Paediatrics, University of Pécs, Hungary | Division of Gastroenterology, First Department of Medicine, University of Pécs, 7624 Pécs, Hungary | Elena Ramírez-Maldonado | Insitute for Translational Medicine, University of Pécs, Medical School, Pécs, Hungary | László Mangel | Medical University of Pecs | University of Pecs | University of Pécs | University of Pecs Department of ENT | University of Pecs, Medical School, Dept.of Anesth Int Care

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Adenocarcinoma (Phase 2)

Angina Pectoris (Phase 3)

Angina, Stable (Phase 3)

Arthritis (Phase 1)

Arthritis, Juvenile (Phase 1)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Diabetic Nephropathies (Phase 2)

Dry Socket (Phase 4)

Edema (Phase 2)

Essential Tremor (Phase 3)

Heart Diseases (Phase 4)

Inflammation (Phase 4)

Kidney Diseases (Phase 2)

Macular Edema (Phase 2)

Myocardial Ischemia (Phase 4)

Prostatic Neoplasms (Phase 2)

Retinal Vein Occlusion (Phase 2)

Sepsis (Phase 2)

Shock (Phase 2)

Syndrome (Phase 4)

Tooth, Impacted (Phase 4)

Toxemia (Phase 2)

Tremor (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 26
  • # of Trial APIs: 31